XML 34 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

(In thousands)

 

Research and development

 

$

24,224

 

 

$

21,235

 

 

$

69,824

 

 

$

60,517

 

General and administrative

 

 

15,395

 

 

 

14,117

 

 

 

44,832

 

 

 

38,490

 

Total

 

$

39,619

 

 

$

35,352

 

 

$

114,656

 

 

$

99,007

 

Summary of Restricted Stock Activity

The following table summarizes the Company’s RSU activity for the nine months ended September 30, 2024:

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair Value
per Share

 

Unvested restricted stock units as of December 31, 2023

 

 

4,041,753

 

 

$

50.40

 

Granted

 

 

3,326,772

 

 

 

33.89

 

Vested

 

 

(1,335,350

)

 

 

51.56

 

Cancelled

 

 

(582,581

)

 

 

43.50

 

Unvested restricted stock units as of September 30, 2024

 

 

5,450,594

 

 

$

40.77

 

Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted Weighted average assumptions used to apply this pricing model were as follows:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2024

 

2023

 

2024

 

2023

Risk-free interest rate

 

4.0%

 

n/a

 

4.2%

 

4.4%

Expected term

 

6.0 years

 

n/a

 

6.0 years

 

6.0 years

Expected volatility of underlying stock

 

75.8%

 

n/a

 

76.3%

 

78.7%

Expected dividend yield

 

0.0%

 

n/a

 

0.0%

 

0.0%

Summary of Stock Option Activity

The following is a summary of stock option activity for the nine months ended September 30, 2024:

 

 

Number of
Options

 

 

Weighted
Average
Exercise
Price per
Share

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(In years)

 

 

(In thousands)

 

Outstanding at December 31, 2023

 

 

5,458,999

 

 

$

50.38

 

 

 

6.65

 

 

$

35,922

 

Granted

 

 

918,161

 

 

 

30.72

 

 

 

 

 

 

 

Exercised

 

 

(371,736

)

 

 

15.69

 

 

 

 

 

 

 

Forfeited

 

 

(526,473

)

 

 

71.23

 

 

 

 

 

 

 

Outstanding at September 30, 2024

 

 

5,478,951

 

 

$

47.43

 

 

 

6.52

 

 

$

11,250

 

Exercisable at September 30, 2024

 

 

4,096,828

 

 

$

47.42

 

 

 

5.76

 

 

$

11,250

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Employee Stock Purchase Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted

The fair value of shares under the 2016 Plan was estimated at the beginning of the offering period using a Black-Scholes option-pricing model with the following assumptions:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2024

 

2023

 

2024

 

2023

Risk-free interest rate

 

5.37%

 

5.53%

 

5.24%-5.37%

 

4.7%-5.53%

Expected term

 

0.5 years

 

0.5 years

 

0.5 years

 

0.5 years

Expected volatility of underlying stock

 

59.0%

 

60.4%

 

56.7%-59.0%

 

60.4%-69.2%

Expected dividend yield

 

0.0%

 

0.0%

 

0.0%

 

0.0%